AR
About
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 58 investors are based in New Haven, Connecticut, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- New Haven, US
Contact Information
Find more investors like Arvinas
Search Investors